Johnson D S, Smith R B
Department of Orthopaedics, Royal Preston Hospital, Sharoe Green Lane, Preston PR2 9HT, UK.
Knee. 2001 Mar;8(1):51-7. doi: 10.1016/s0968-0160(01)00068-0.
There is increasing pressure within the United Kingdom for transparent assessment of the performance of every doctor along with the procedures they perform. Unfortunately, the validation of the outcome measures used to assess such procedures has been questioned. This has been well illustrated in the anterior cruciate ligament (ACL) deficient knee. Over 54 different outcome measures used to assess the ACL deficient knee have been identified, few of which were formally assessed at their initial publication. For those most frequently used the Lysholm (I and II) knee scoring scale and Tegner activity score are the only ones to have been adequately validated prior to use. The Cincinnati rating system and International Knee Documentation Committee (IKDC) form were not assessed and the reliability of both measures has since been questioned. Appropriately tested newer measures include the IKDC subjective knee evaluation form, Mohtadi's ACL quality of life outcome measure and the Knee injury and osteoarthritis outcome score (KOOS). We recommend use of the Lysholm II knee scoring scale and Tegner activity score for clinical follow-up of patients and for use as a gold standard to which future measures can be compared. These have their deficiencies and will ultimately require replacement. In view of the international standing of its authors, the IKDC subjective knee evaluation form is likely to be used in preference to the KOOS despite its attractions. For long-term clinical trials the SF-36 should also be used. Further research is required to produce suitable measures for assessing the ACL deficient knee and this work should be appropriately funded.
在英国,对每位医生的表现及其所执行的程序进行透明评估的压力越来越大。不幸的是,用于评估此类程序的结果指标的有效性受到了质疑。这在前交叉韧带(ACL)损伤的膝关节中得到了很好的体现。已确定超过54种用于评估ACL损伤膝关节的不同结果指标,其中很少有在最初发表时进行过正式评估。对于那些最常用的指标,Lysholm(I和II)膝关节评分量表和Tegner活动评分是仅有的在使用前经过充分验证的指标。辛辛那提评分系统和国际膝关节文献委员会(IKDC)表格未经过评估,此后这两种指标的可靠性都受到了质疑。经过适当测试的较新指标包括IKDC主观膝关节评估表格、Mohtadi的ACL生活质量结果指标以及膝关节损伤和骨关节炎结果评分(KOOS)。我们建议使用Lysholm II膝关节评分量表和Tegner活动评分对患者进行临床随访,并作为未来指标可与之比较的金标准。这些指标有其不足之处,最终将需要被取代。鉴于其作者的国际地位,尽管KOOS有吸引力,但IKDC主观膝关节评估表格可能会更受青睐。对于长期临床试验,还应使用SF - 36。需要进一步研究以产生评估ACL损伤膝关节的合适指标,并且这项工作应获得适当的资金支持。